Charles Elliott Sigal Insider Trading $ADAP Adaptimmune Therapeutics PLC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles Elliott Sigal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles Elliott Sigal. Charles Elliott Sigal is Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in Surface Oncology, Inc. ($SURF) and Director in Vir Biotechnology, Inc. ($VIR).
Charles Elliott Sigal in Adaptimmune Therapeutics PLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Charles Elliott Sigal: Director
Holdings: 314,100 shares
Current Value: $1,422,873
Latest Transaction: Jul 01 2020
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Charles Elliott Sigal in Adaptimmune Therapeutics PLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, SURF, VIR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 01 2020 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Option Exercise | A | 1.67 | 184,258 | 307,711 | 184,258 | |
| Jul 03 2019 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Option Exercise | A | 0.61 | 234,407 | 142,988 | 234,407 | |
| Jun 26 2018 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Option Exercise | A | 2.18 | 154,809 | 337,484 | 154,809 | |
| Jul 03 2017 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Option Exercise | A | 0.75 | 220,788 | 165,591 | 220,788 | |
| Aug 12 2016 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Option Exercise | A | 1.27 | 184,562 | 234,394 | 184,562 | |
| May 19 2016 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Buy | P | 1.56 | 15,000 | 23,400 | 314,100 | 299.1 K to 314.1 K (+5.02 %) |
| May 18 2016 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Buy | P | 1.55 | 15,000 | 23,250 | 299,100 | 284.1 K to 299.1 K (+5.28 %) |
| May 18 2016 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Buy | P | 1.53 | 15,000 | 22,950 | 284,100 | 269.1 K to 284.1 K (+5.57 %) |
| May 18 2016 | ADAP | Adaptimmune Therap ... | Sigal Charles Elliott | Director | Buy | P | 1.50 | 15,000 | 22,500 | 269,100 | 254.1 K to 269.1 K (+5.90 %) |
Page: 1